Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study - Mao, X; Zhang, X; Lai, R (Clin Mol Hepatol, 2025)